
High Exposure to the US ‘Doesn't Make Sense': Nomura's Nicholson
Maintaining an overweight exposure to US equities 'doesn't make sense,' Nomura's Gareth Nicholson tells Bloomberg. Speaking on The China Show, Nicholson advises traders to diversify their assets internationally. He also cautions investors to stay vigilant for potential geopolitical upsets stemming from a lack of progress in the US-China trade impasse. Despite some positive signals, Nicholson warns that markets could unwind rapidly in response to disappointing news. (Source: Bloomberg)

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
16 minutes ago
- Yahoo
China's Biggest Soy Sauce Maker Rises in Hong Kong Trading Debut
Foshan Haitian Flavouring & Food Co., China's biggest soy sauce maker, rose 3.3% on its Hong Kong trading debut on Thursday. That's after its HK$10.1 billion ($1.3 billion) stock offering drew strong demand from investors. Bloomberg's Manuel Baigorri reports. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
22 minutes ago
- Yahoo
Trip.com (TCOM) Drops as E-Commerce Giant Emerges as Potential Competitor
We recently published a list of 10 Stocks Take A Shocking Nosedive. Group Limited (NASDAQ:TCOM) is one of the worst-performing stocks on Thursday. Group saw its share prices drop by 6.81 percent on Wednesday to finish at $56.54 apiece following news that one of China's e-commerce giants is making foray into the travel sector with a hotel membership program. In an open letter to hoteliers, said that it would provide supply-chain services without any commission for three years in a bid to lower operational costs, enhance guest experience, and support consumer traffic to hoteliers. The announcement weighed in on investor sentiment for Group Limited (NASDAQ:TCOM), one of the leading multinational travel agencies globally. Group Limited's (NASDAQ:TCOM) drop followed the company's 'buy' recommendation from investment firm Jefferies, with a price target of $80. A customer in a travel agents office, highlighting the convenience of the companies corporate travel solutions. According to Jefferies, its analysis reflected its share repurchase agreement with MakeMyTrip, under which, Group Limited (NASDAQ:TCOM) will sell a portion of its Class B ordinary shares back to MakeMyTrip for cancellation. While we acknowledge the potential of TCOM as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
28 minutes ago
- Yahoo
Insilico Medicine's Aliper on Business Outlook
Alex Aliper, Co-founder & President of AI-drug company, Insilico Medicine, discusses why China is a stand-out market for pharmaceuticals and biotech, and says the company plans to invest in research to accelerate business growth and drug development. He speaks with Annabelle Droulers on the sidelines of SuperAI Conference in Singapore on "Bloomberg: The Asia Trade". Sign in to access your portfolio